This page allows you to read information about people engaged in research at CAMH. You can search for researchers using the
name or keyword search engine below.
Dr. James L. Kennedy
Psychiatric Neurogenetics Section Centre for Addiction and Mental Health 250 College Street Toronto, Ontario M5T 1R8 (416) 535-8501 ext. 4987 james_kennedy@camh.net
Dr. James L. Kennedy is Director of the Neuroscience Research Department and Head of the Psychiatric Neurogenetics Section. He is the I'Anson Professor in the Department of Psychiatry and Institute of Medical Science at the University of Toronto.
Dr. Kennedy's research is dedicated to finding genes involved in the cause of mental illness. He has published pioneering findings relating gene variants in the dopamine, serotonin, and neurodevelopment systems to psychiatric disorders, and to treatment response. Dr. Kennedy has also led important investigations of unstable DNA mutation in mental illness. Currently he is applying molecular genetic technology to the study of schizophrenia, childhood depression, manic depression, anxiety disorders, eating disorders, addictions, and attention deficit hyperactivity disorder. In addition, Dr. Kennedy is investigating genetic factors that may predict response and side effects to psychiatric medications (pharmacogenetics). Another important area of interest is the integration of molecular genetics and neuroimaging (MRI, PET) as a combination approach to better understand brain structure and function.